Summer Sale
50% off Premium Yearly
NASDAQ:SLS
Sellas Life Sciences Group Inc (SLS)
Financials 
Technical Analysis 
Jun 11, 2026, 12:00 amThis summary was created by AI, based on 1 opinions in the last 12 months.
Sellas Life Sciences Group Inc (SLS-Q) recently reported its operating expenses for the quarter at $7.1 million, reflecting a 3.1% increase from the previous quarter. This rise in operating expenses may indicate ongoing investments aimed at growth or potential inefficiencies that need to be addressed. Meanwhile, the company's net income for the quarter was reported at -$6.8 million, which is a slight decrease of 2.9% from the last quarter. This decline in net income raises some concerns regarding the company's financial health, although it may also reflect one-time costs or strategic investments. Notably, social media mentions have surged by 14.4% in the past 24 hours, suggesting increased interest or awareness around the company. Stakeholders should remain vigilant about the financial metrics while assessing the company's growth trajectory and public perception.
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium content
- «
- ‹
- 1
- ›
- »
Sellas Life Sciences Group Inc (SLS) Frequently Asked Questions
What is Sellas Life Sciences Group Inc stock symbol?
Sellas Life Sciences Group Inc is a American stock, trading under the symbol SLS (previously SLS-Q on Stockchase) on the NASDAQ (SLS). It is usually referred to as NASDAQ:SLS or SLS
Is Sellas Life Sciences Group Inc a buy or a sell?
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on SLS (previously SLS-Q on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Sellas Life Sciences Group Inc.
Is Sellas Life Sciences Group Inc a good investment or a top pick?
Sellas Life Sciences Group Inc was recommended as a Top Pick by The Weekly Buzzing Stocks by Billy Kawasaki on 2026-01-08. Read the latest stock experts ratings for Sellas Life Sciences Group Inc.
Why is Sellas Life Sciences Group Inc stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Sellas Life Sciences Group Inc.
Is Sellas Life Sciences Group Inc worth watching?
Sellas Life Sciences Group Inc is covered by Stockchase experts and is worth watching.
What is Sellas Life Sciences Group Inc stock price?
On 2026-06-12, Sellas Life Sciences Group Inc (SLS) stock closed at a price of $7.83.
Operating Expenses for this period were 7.1M, showing a 3.1% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas. Net Income for the quarter was -6.8M, showing a -2.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments. Social media mentions are up 14.4% in the past 24h.